Digital Therapeutics
Total Trials
17
As Lead Sponsor
16
As Collaborator
1
Total Enrollment
2,959
NCT02656745
Clinical Trial of Smoking Cessation Mobile Phone Program
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2016
Completion: Jun 30, 2017
NCT05440721
Clinical Trial of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification
Start: Oct 25, 2018
Completion: Aug 31, 2022
NCT04907942
Ecological Momentary Assessment and Text Message Intervention for Stress Management
Start: Oct 29, 2020
Completion: Jun 20, 2021
NCT04770285
Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder
Role: Collaborator
Start: Feb 25, 2021
Completion: Oct 26, 2022
NCT04857515
Clinical Learning Study for a Mobile Smoking Cessation Program
Start: Mar 12, 2021
Completion: Jun 28, 2021
NCT05438160
Exploratory Study of a Digital Therapeutics in People With Schizophrenia
Start: Mar 31, 2022
Completion: Jul 31, 2022
NCT05438147
Effects of a CT-100 DiNaMo Component on Cognitive Functioning and Mood Symptoms
Start: May 13, 2022
Completion: Sep 6, 2022
NCT05486312
7-week Study With CT-155 in People With Schizophrenia
Start: Jul 5, 2022
Completion: Dec 12, 2022
NCT05573685
Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training
Start: Oct 10, 2022
Completion: Feb 6, 2023
NCT05853900
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine
Start: Mar 28, 2023
Completion: May 7, 2024
NCT05838625
Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia
Phase: Phase 3
Start: Mar 31, 2023
Completion: Jul 23, 2025
NCT06004388
Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C)
Start: Jul 21, 2023
Completion: Jun 5, 2024
NCT06067984
An Extension Study of a Second Course of a Digital Therapeutic for the Treatment of Experiential Negative Symptoms of Schizophrenia
Start: Sep 12, 2023
Completion: Aug 22, 2025
NCT06136936
A Study to Evaluate the Overall Effects of Treatment With Abbreviated CT-156 in People With Schizophrenia
Start: Sep 20, 2023
Completion: Feb 22, 2024
NCT06136923
An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer
Start: Oct 19, 2023
Completion: May 6, 2024
NCT06275659
An Exploratory Study to Evaluate a Digital Intervention to Disrupt Scratching in Atopic Dermatitis and Psoriasis
Start: Dec 4, 2023
Completion: Feb 23, 2024
NCT06486948
An Exploratory, Double-arm, 8-week Study to Explore the Feasibility and Acceptability of Abbreviated Treatment with CT-156 in People with Schizophrenia.
Start: May 6, 2024
Completion: Aug 9, 2024
Loading map...